EP2294083
IL-17A og IL-17F vakaeiningar og sértæk mótefni þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.4.2009EP published:
29.7.2015EP application number:
09735498.9
EP translation filed:
5.10.2015Grant published:
15.10.2015EPO information:
European Patent Register
Max expiry date:
21.4.2029Expiry date:
21.4.2026Next due date:
30.4.2026
Title:
EPITOPES OF IL-17A AND IL-17F AND ANTIBODIES SPECIFIC THERETO
Timeline
Today
22.4.2009EP application
29.7.2015EP Publication
5.10.2015Translation submitted
15.10.2015Registration published
21.4.2026Expires
Owner
Name:
UCB Biopharma SPRLAddress:
Allée de la Recherche 60, 1070, Brussels, BE
Inventor
Name:
CESKA, Thomas, AllenAddress:
Berkshire SL1 3WE, GB
Name:
HENRY, Alistair, JamesAddress:
Berkshire SL1 3WE, GB
Name:
SHI, JijyeAddress:
Rochester, NY, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0807413Date:
23.4.2008Country:
GB
Classification
Categories:
C07K 14/54, C07K 16/24
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 11.3.2016
Expires: 21.4.2017
Payer: Árnason Faktor
Number: 9
Paid: 7.3.2017
Expires: 21.4.2018
Payer: Árnason Faktor
Number: 10
Paid: 5.3.2018
Expires: 21.4.2019
Payer: Árnason Faktor
Number: 11
Paid: 8.3.2019
Expires: 21.4.2020
Payer: Árnason Faktor
Number: 12
Paid: 10.3.2020
Expires: 21.4.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 10.3.2021
Expires: 21.4.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 10.3.2022
Expires: 21.4.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 8.3.2023
Expires: 21.4.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 7.3.2024
Expires: 21.4.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 18.3.2025
Expires: 21.4.2026
Payer: Árnason Faktor ehf.